Compositions and methods for stimulating bone growth
CA 2274789 A1 · Owner: Osteoscreen, Inc. · Inventors: Baindur, Nand; Robbins, Kirk G.; Mckernan, Patricia A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of formulas (1) and (2), wherein the variables of X Y and R' are , herein defined in the specification promote bone information and are thus useful in treating osteoporosis, bone fracture or deficiency primary or , secondary hyperparathyroidism periodontal disease or defect, metastatic bone disease, osteolytic bone disease, post-plastic surgery post-prosthetic joint , surgery, and post-dental implantation. The figure shows the structure and activity of several compounds of the invention namely nevastatin, lovastatin , and pravastatin as tested in the in vitro BMP-promoter based assay.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 12, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 12, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 12, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.